121 – 130 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complement C4 copy number variation is linked to SSA/Ro and SSB/La autoantibodies in systemic inflammatory autoimmune diseases
(
- Contribution to journal › Article
-
Mark
Population-based study of multisystem inflammatory syndrome associated with COVID-19 found that 36% of children had persistent symptoms
2022) In Acta Paediatrica, International Journal of Paediatrics(
- Contribution to journal › Article
-
Mark
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Comparison of chronic widespread pain prevalence with different criteria in two cohorts of rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
(
- Contribution to journal › Article
-
Mark
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity : 52-Week Post Hoc Results from SPIRIT-H2H
(
- Contribution to journal › Article
-
Mark
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA) : A Retrospective Observational Study
(
- Contribution to journal › Article
-
Mark
Neutrophils Lose the Capacity to Suppress T Cell Proliferation Upon Migration Towards Inflamed Joints in Juvenile Idiopathic Arthritis
(
- Contribution to journal › Article
-
Mark
Global epidemiology of vasculitis
(
- Contribution to journal › Scientific review
-
Mark
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis
(
- Contribution to journal › Article